New published data show otoprotective effect of AM-111 in case of inner ear inflammatory responses (acute labyrinthitis)
A scientific article titled “AM-111 reduces hearing loss in a guinea pig model of acute labyrinthitis” in the December 2007 issue of the American journal Laryngoscope is presenting new data on AM-111, Auris Medical’s intracellular apoptosis inhibitor. It contains the main results of a study which was conducted jointly by the University of California at San Diego, the Veterans Medical Research Foundation and Auris Medical, and directed by Elizabeth M. Keithley, PhD.
